ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2117

Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort

Alfredo Aguirre1, S. Sam Lim2, Gaobin Bao3, Charles T. Molta4, Hong Kan5 and Cristina Drenkard6, 1Department of Rheumatology, Emory University, Atlanta, GA, 2Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 3Medicine, Emory University, Atlanta, GA, 4GlaxoSmithKline, King of Prussia, PA, 55 Moore Dr, GSK, Durham, NC, 6Medicine, Div Rheumatology, Emory University, Atlanta, GA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Activity score, Depression and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose . Frequent visitors of the emergency department (ED) among the general population share several demographic, health system and disease characteristics, including older age, poverty, government-financed insurance and poorer health. The burden of depression is also high among frequent ED visitors. Depression strikes up to 75% of SLE patients and is more severe among blacks compared to whites. Previous reports among predominantly white SLE samples suggest that there is an association between depression and ED usage.  We sought to examine whether the severity of depressive symptoms increases the risk of being a frequent user of the ED in a predominantly black SLE cohort in the Southeastern US.

Methods . Georgians Organized Against Lupus (GOAL) is a longitudinal cohort largely drawn from a population-based registry of people with SLE, which has been established in Atlanta, GA. Annual surveys furnish self-administered data on demographics, disease outcomes and healthcare utilization. Over 75% of participants are black, and 35% live under the poverty level. We used the 9-item Patient Health Questionnaire (PHQ-9) to assess severity of depressive symptoms. PHQ-9 can be assessed as a continuous (score range 0-27) or categorical (5 categories from minimal to severe depressive symptoms) variable. Individuals who visited the ED ≥ 3 times in the past year were considered frequent ED users.  We conducted logistic regression analyses to test the effect of depression severity on being a frequent ED user, after controlling for potential confounders.

Results . Of 566 SLE participants, 96 (17%) visited the ED at least 3 times in the past year. Frequent usage of the ED was found in 10%, 17%, 26%, 24%, and 28% of patients with minimal, mild, moderate, moderately severe, and severe symptoms of depression, respectively. Severity of depressive symptoms, demographic factors, type of insurance, disease activity, and organ damage were associated with frequent ED utilization (Table 1). The PHQ-9 score remained positively associated with the outcome after controlling for major confounders. PHQ-9 and self-reported disease activity (SLAQ) scores were highly correlated (rho=0.65). The association between the PHQ-9 score and frequent ED usage was not longer significant when SLAQ was included in the model (OR=0.98; p=0.85).

Conclusion . Our data suggest that the severity of depressive symptoms may modulate healthcare-seeking behavior in SLE.  However, other factors often disproportionately prevalent among socioeconomically disadvantaged subgroups with SLE, such as severe organ damage, greater disease activity and being on Medicaid showed stronger association with the outcome. Longitudinal studies are needed to tease out the complex pathways implicated in the usage of avoidable healthcare resources among minorities with SLE, particularly among those stricken by depressive symptoms.

Table 1. Association of Depressive Symptoms with Frequent Usage of the Emergency Department

Characteristics

Univariable LR

Multivariable LR (stepwise)

Odds Ratio

P Value

Odds Ratio

P Value

Depressive symptoms (5-unit increase in PHQ-9 score)

1.43 (1.21-1.70)

<0.0001

1.30 (1.07-1.59)

0.009

Age at diagnosis (5 year increase)

0.91 (0.83-1.00)

0.051

0.85 (0.75-0.95)

0.006

Gender (female)

0.79 (0.35-1.79)

0.58

Race (non-white)

2.68 (1.31-5.52)

0.0073

2.22 (0.95-5.19)

0.07

Disease duration (1 year increase)

0.99 (0.96-1.01)

0.29

0.96 (0.93-0.99)

0.009

Educational attainment (3 year increase)

0.80 (0.63-1.00)

0.051

Household income below poverty level

2.90 (1.81-4.63)

<0.0001

Insurance type (ref: Private)

    No Insurance

2.83 (1.17-6.84)

0.021

1.83 (0.71-4.75)

0.80

    Medicare 

3.29 (1.65-6.55)

0.0007

2.30 (1.08-4.90)

0.50

    Medicaid

6.27 (3.22-12.23)

<0.0001

3.63 (1.76-7.47)

0.003

Married or living with partner

0.59 (0.37-0.94)

0.028

Disease activity (5-unit increase in SLAQ score)

1.65 (1.44-1.88)

<0.0001

Not included*

Organ damage (SA-BILD score)

    Mild damage (1-2) vs. no damage (0)

2.07 (0.95-4.51)

0.067

1.89 (0.82-4.34)

0.76

    Severe damage (³3) vs. no damage (0)

4.91 (2.34-10.33)

<0.0001

4.26 (1.84-9.86)

0.0001

Abbreviations: LR: logistic regression; PHQ-9: 9-item Patient Health Questionnaire; SA-BILD: Self-administered Brief Index Lupus Damage; SLAQ: Systemic Lupus Activity Questionnaire. * Because SLAQ was highly correlated with PHQ-9 (Pearson correlation coefficient =0.65; p<0.0001), it was not included in the multivariate model.


Disclosure:

A. Aguirre,
None;

S. S. Lim,

NIH,

2,

GlaxoSmithKline,

2,

Emory University,

3;

G. Bao,

GlaxoSmithKline,

2,

Emory University,

3;

C. T. Molta,

GSK,

1,

GSK,

3;

H. Kan,

GSK,

1,

GSK,

3;

C. Drenkard,

NIH,

2,

Emory,

3,

GlaxoSmithKline ,

2.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-depression-and-high-utilization-of-emergency-department-in-patients-with-systemic-lupus-erythematosus-from-the-southeastern-united-states-the-goal-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology